Grant: Catalyst Grant: Human Microbiome
University of Ottawa
$98,000.00
Role of the gut microbiome in Pediatric Gastrointestinal Illnesses
EF 2008-09
Résumé
The causes for development of chronic gastrointestinal illnesses remain uncertain. Recent studies suggest that the type of bacteria that are in the intestinal tract of people may be important in staying healthy and an imbalance of the types of bacteria is associated with development of diseases or conditions such as Crohn's disease, ulcerative colitis or Irritable Bowel Syndrome. Inflammatory Bowel Disease (IBD) is the most common incurable chronic gastrointestinal illness in children and adolescents, with up to 30% of IBD patients developing disease before adulthood. More concerning, the number of IBD cases in children appears to be on the rise. Here, we propose to perform a comprehensive analysis of the gastrointestinal tract microbial population in children with IBD. We will test the hypothesis that the composition of the mucosa-associated microbes (bacteria and virus) and/or mobile DNA elements of this microbial population is a characteristic of the disease type, namely Crohn's disease and ulcerative colitis. Specifically, we will compare the types of microbes that are present right in the intestinal tract of those patients with Crohn's disease, ulcerative colitis, irritable bowel syndrome from otherwise healthy children without these conditions using DNA sequencing and high-throughput genomic approaches. The proposed pilot study will define a microbial "fingerprint" for each of these illnesses and will significantly increase our understanding of the role of the gut microbial population in the maintenance of health and/or development of disease. In turn, the gained knowledge could be used to guide future hypothesis-driven research aimed at manipulating the gut microbial population to treat disease or maintain human health.
Programme
Catalyst Grant: Human Microbiome
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
172974
Name
Stintzi Alain
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Catalyst Grant: Human Microbiome
Projecttitle
Role of the gut microbiome in Pediatric Gastrointestinal Illnesses
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$98,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Human Microbiome
Keyworddelim
16s Rdna Sequencing And Microarray; Crohn'S Disease And Ulcerative Colitis; Human Microbiome; Inflamatory Bowel Syndrome; Metagenomic; Pediatric Patients
Abstract
The causes for development of chronic gastrointestinal illnesses remain uncertain. Recent studies suggest that the type of bacteria that are in the intestinal tract of people may be important in staying healthy and an imbalance of the types of bacteria is associated with development of diseases or conditions such as Crohn's disease, ulcerative colitis or Irritable Bowel Syndrome. Inflammatory Bowel Disease (IBD) is the most common incurable chronic gastrointestinal illness in children and adolescents, with up to 30% of IBD patients developing disease before adulthood. More concerning, the number of IBD cases in children appears to be on the rise. Here, we propose to perform a comprehensive analysis of the gastrointestinal tract microbial population in children with IBD. We will test the hypothesis that the composition of the mucosa-associated microbes (bacteria and virus) and/or mobile DNA elements of this microbial population is a characteristic of the disease type, namely Crohn's disease and ulcerative colitis. Specifically, we will compare the types of microbes that are present right in the intestinal tract of those patients with Crohn's disease, ulcerative colitis, irritable bowel syndrome from otherwise healthy children without these conditions using DNA sequencing and high-throughput genomic approaches. The proposed pilot study will define a microbial "fingerprint" for each of these illnesses and will significantly increase our understanding of the role of the gut microbial population in the maintenance of health and/or development of disease. In turn, the gained knowledge could be used to guide future hypothesis-driven research aimed at manipulating the gut microbial population to treat disease or maintain human health.
Competitiondate
200808
Approvedterm2
1 yr 0 mth
Pinamesdelim
Stintzi, Alain
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Infection & Immunity~ $32,000~ $0~Inst of Nutr Metabolism &Diab~ $66,000~ $0~